HALISTER: Gilead’s Hepatitis C Combo Cuts Cure to Six Weeks, Fails at Four

Gilead’s Hepatitis C Combo Cuts Cure to Six Weeks, Fails at Four

Alert: HALISTER Source: BN (Bloomberg News)

Tickers GILD US (Gilead Sciences Inc) ABBV US (AbbVie Inc)

People Gregg Alton (Gilead Sciences Inc) Michael J Yee (RBC Capital Markets)

Topics Viral Hepatitis

To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.

UUID: 7947283